NeuroHealing Pharmaceuticals to Present at Rodman & Renshaw Techvest Seventh Annual HealthCare Conference

NEWTON, MA, November 3, 2005. NeuroHealing Pharmaceuticals, Inc., a private company developing therapeutic products for individuals with chronic brain injuries, today announced that Neal M. Farber, Ph.D., CEO of NeuroHealing, is scheduled to present at the upcoming Rodman & Renshaw Techvest Seventh Annual Healthcare Conference. Dr. Farber will present information on NeuroHealing’s three clinical stage…

NeuroHealing Pharmaceuticals announces IND submission for NH001 to improve the outcome of patients in a vegetative state following a traumatic brain injury

Newton, Mass., August 31, 2005 — E-Worldwire NeuroHealing Pharmaceuticals Inc., a private company developing products for individuals with chronic brain injuries, announced today the submission of an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase II clinical trial with NH001. The study is entitled “A Double-Blind,…

Harvard Biotechnology Club Awards NeuroHealing Pharmaceuticals First Prize in Business Plan Competition

Boston, June 14, 2004 – PRNewswire In the 2004 Biotechnology Business Plan Competition organized by the GSAS Harvard Biotechnology Club, NeuroHealing Pharmaceuticals Inc., a pharmaceutical company focused on the development of treatments for the neuro-rehabilitation market, was awarded first prize by the panel of judges comprised of members of leading venture capital firms. At the…